Sana Biotechnology, Inc.
SANA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $209 | $220 | $201 | $306 |
| G&A Expenses | $64 | $73 | $72 | $50 |
| SG&A Expenses | $64 | $73 | $72 | $50 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $273 | $293 | $273 | $357 |
| Operating Income | -$273 | -$293 | -$273 | -$357 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $6 | $10 | $3 | $1 |
| Pre-Tax Income | -$267 | -$283 | -$269 | -$356 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$267 | -$283 | -$269 | -$356 |
| % Margin | – | – | – | – |
| EPS | -1.16 | -1.46 | -1.43 | -2.14 |
| % Growth | 20.5% | -2.1% | 33.2% | – |
| EPS Diluted | -1.16 | -1.46 | -1.43 | -2.14 |
| Weighted Avg Shares Out | 231 | 195 | 188 | 166 |
| Weighted Avg Shares Out Dil | 231 | 195 | 188 | 166 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10 | $10 | $4 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $17 | $25 | $16 | $11 |
| EBITDA | -$255 | -$269 | -$257 | -$346 |
| % Margin | – | – | – | – |